Last reviewed · How we verify

NCT03248726

Comparing Single-dose Low-volume PEG Plus Bisacodyl vs. Split-dose PEG for Bowel Preparation in Morning Colonoscopy

Completed NA Last updated 29 October 2019
What this trial tests

NA trial testing Polyethylene glycol and bisacodyl in Bowel Preparation in 122 participants. Completed in 30 September 2019.

Timeline
14 July 2017
Primary endpoint
30 September 2019
30 September 2019

Quick facts

Lead sponsorTaipei Medical University WanFang Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposediagnostic
Enrollment122
Start date14 July 2017
Primary completion30 September 2019
Estimated completion30 September 2019
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Taipei Medical University WanFang Hospital

Who can join

Adults 20 to 70, any sex, with Bowel Preparation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Colonoscopy is the best method to detect colorectal cancer and colonic polyps. Studies showed that adenoma detection rate positive correlation with good bowel preparation which makes bowel preparation an important issue. Hence, investigators conduct a clinical trial about adding another laxative agent to morning single dose low-volume PEG. To see if this new regimen could have non-inferior efficacy and lower life/sleep impact compared with standard regimen.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Bowel Preparation

Currently open trials in the same condition.

Other Taipei Medical University WanFang Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03248726.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing